Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIB vs CI Ropivacaine for Ankle Surgery Analgesia
NCT02707874Phase 4Unknown
- Sponsor
- University Health Network
- Start
- Oct 2014
- Primary completion
- Dec 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University Health Network. Primary endpoint: Average numerical rating score for pain at 48 hours. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02707874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707874.